A new article has recently been published in the Asia Pacific Journal of Clinical Oncology reporting the incidence, prevalence, and survival trends for Neuroendocrine Neoplasms (NENs) in Victoria between 1982 and 2019.
This important epidemiological study, conducted by leading neuroendocrine researchers at the Victorian Cancer Registry and Peter MacCallum Cancer Centre, identified a total of 8106 neuroendocrine neoplasm cases between 1982 and 2019 through the Victorian Cancer Registry. The majority of these were grade 1 or 2 NENs with highest prevalence rates noted for colorectal and small bowel NENs.
In terms of incidence, the age-standardised incidence rates increased over time, particularly in pancreatic NENs which showed a 7.7-fold increase in terms of primary sites. Prevalence also rose across all primary sites over the three decades with the most notable increases in small bowel, colorectal and lung NENs.
In good news, the 5-year overall survival rates showed improvement for the cohort overall from 52% to 67%, although disparities in survival rates were noted, with better outcomes reported for metropolitan compared to regional/remote patients.
Find out more by reading the full article now.